
The Opterion Health AG team welcomes Marc Willuhn!
Marc has recently joined as Head CMC and provides scientific guidance, projectmanagement support and regulatory expertise in the field of chemistry, manufacturing and controls (CMC). He has more than 20 years of experience in drug development for global markets, and held senior leadership roles at Fresenius Kabi and Baxter Healthcare. Marc is an excellent addition to our team and will define, drive and oversee Opterion Health AG’s pharmaceutical development and manufacturing activities for preclinical and